Global Diabetes Drugs Market Research Report 2019

Table of Contents

1 Diabetes Drugs Market Overview 1

• 1.1 Product Overview and Scope of Diabetes Drugs 1
• 1.2 Diabetes Drugs Segment by Types 1
  • 1.2.1 Global Diabetes Drugs Sales Growth Rate Comparison by Types (2013-2025) 1
  • 1.2.2 Insulin 2
  • 1.2.3 DPP-4 3
  • 1.2.4 GLP-1 4
  • 1.2.5 SGLT-2 5
• 1.3 Diabetes Drugs Segment by Applications 6
  • 1.3.1 Global Diabetes Drugs Sales Comparison by Applications (2018-2025) 6
  • 1.3.2 Type 1 Diabetes 7
  • 1.3.3 Type 2 Diabetes 7
• 1.4 Global Diabetes Drugs Market by Regions 8
  • 1.4.1 Global Diabetes Drugs Market Size by Regions 8
  • 1.4.2 North America Diabetes Drugs Status and Prospect (2013-2025) 9
  • 1.4.3 Europe Diabetes Drugs Status and Prospect (2013-2025) 9
  • 1.4.4 China Diabetes Drugs Status and Prospect (2013-2025) 10
  • 1.4.5 India Diabetes Drugs Status and Prospect (2013-2025) 11
• 1.5 Global Diabetes Drugs Market Size 11
  • 1.5.1 Global Diabetes Drugs Revenue (2013-2025) 11
  • 1.5.2 Global Diabetes Drugs Sales (2013-2025) 12

2 Global Diabetes Drugs Market Competition by Manufacturers 13

• 2.1 Global Diabetes Drugs Sales Market Share by Manufacturers (2013-2018) 13
• 2.2 Global Diabetes Drugs Revenue Market Share by Manufacturers (2013-2018) 15
• 2.3 Global Diabetes Drugs Average Price by Manufacturers (2013-2018) 17
• 2.4 Manufacturers Diabetes Drugs Manufacturing Sites, Area Served, Product Types 18
• 2.5 Diabetes Drugs Market Competitive Situation and Trends 20
  • 2.5.1 Diabetes Drugs Market Concentration Rate 20
  • 2.5.2 Diabetes Drugs Market Share of Top 3 and Top 5 Manufacturers 21
  • 2.5.3 Mergers & Acquisitions, Expansion 22

3 Global Diabetes Drugs Sales by Regions (2013-2018) 23

• 3.1 Global Diabetes Drugs Sales Market Share by Regions 23
• 3.2 Global Diabetes Drugs Revenue Market Share by Regions (2013-2018) 25
• 3.3 Global Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 27
• 3.4 North America Diabetes Drugs Sales 27
  • 3.4.1 North America Diabetes Drugs Sales Growth Rate (2013-2018) 27
  • 3.4.2 North America Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 28
• 3.5 Europe Diabetes Drugs Sales 28
  • 3.5.1 Europe Diabetes Drugs Sales Growth Rate (2013-2018) 28
  • 3.5.2 Europe Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 29
• 3.6 China Diabetes Drugs Sales (2013-2018) 29
  • 3.6.1 China Diabetes Drugs Sales Growth Rate (2013-2018) 29
  • 3.6.2 China Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 30
• 3.7 India Diabetes Drugs Sales (2013-2018) 30
  • 3.7.1 India Diabetes Drugs Sales Growth Rate (2013-2018) 30
  • 3.7.2 India Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 31

4 Global Diabetes Drugs Sales, Revenue, Price Trend by Types 32

• 4.1 Global Diabetes Drugs Sales Market Share by Types (2013-2018) 32
• 4.2 Global Diabetes Drugs Revenue Market Share by Types (2013-2018) 34
• 4.3 Global Diabetes Drugs Price by Type (2013-2018) 36
• 4.4 Global Diabetes Drugs Sales Growth by Type (2013-2018) 36

5 Global Diabetes Drugs Market Analysis by Applications 37

• 5.1 Global Diabetes Drugs Sales Market Share by Applications (2013-2018) 37
• 5.2 Global Diabetes Drugs Sales Growth Rate by Applications (2013-2018) 39

6 Analysis of Diabetes Drugs Industry Key Manufacturers 40

• 6.1 Sanofi 40
  • 6.1.1 Company Profile 40
  • 6.1.2 Product Information 41
  • 6.1.3 Sales, Price, Cost, Gross Profit, and Revenue 42
• 6.2 Merck & Co., Inc. 42
  • 6.2.1 Company Profile 42
  • 6.2.2 Product Information 43
  • 6.2.3 Sales, Price, Cost, Gross Profit, and Revenue 44
• 6.3 Novo Nordisk 44
  • 6.3.1 Company Profile 44
  • 6.3.2 Product Information 45
  • 6.3.3 Sales, Price, Cost, Gross Profit, and Revenue 46
• 6.4 Eli Lilly and Company 46
  • 6.4.1 Company Profile 46
  • 6.4.2 Product Information 47
  • 6.4.3 Sales, Price, Cost, Gross Profit, and Revenue 48
• 6.5 Boehringer Ingelheim 48
  • 6.5.1 Company Profile 48
  • 6.5.2 Product Information 50
  • 6.5.3 Sales, Price, Cost, Gross Profit, and Revenue 50
• 6.6 Novartis 51
  • 6.6.1 Company Profile 51
  • 6.6.2 Product Information 52
  • 6.6.3 Sales, Price, Cost, Gross Profit, and Revenue 52
• 6.7 Johnson & Johnson 53
  • 6.7.1 Company Profile 53
  • 6.7.2 Product Information 54
  • 6.7.3 Sales, Price, Cost, Gross Profit, and Revenue 54
• 6.8 AstraZeneca 55
  • 6.8.1 Company Profile 55
  • 6.8.2 Product Information 56
  • 6.8.3 Sales, Price, Cost, Gross Profit, and Revenue 56
• 6.9 Takeda 57
  • 6.9.1 Company Profile 57
  • 6.9.2 Product Information 58
  • 6.9.3 Sales, Price, Cost, Gross Profit, and Revenue 58
• 6.10 Bayer 59
  • 6.10.1 Company Profile 59
  • 6.10.2 Product Information 60
  • 6.10.3 Sales, Price, Cost, Gross Profit, and Revenue 60
• 6.11 Tonghua DongBao 61
  • 6.11.1 Company Profile 61
  • 6.11.2 Product Information 62
  • 6.11.3 Sales, Price, Cost, Gross Profit, and Revenue 62
• 6.12 Hua Dong 63
  • 6.12.1 Company Profile 63
  • 6.12.2 Product Information 64
  • 6.12.3 Sales, Price, Cost, Gross Profit, and Revenue 64
• 6.13 Ganlee 65
  • 6.13.1 Company Profile 65
  • 6.13.2 Product Information 66
  • 6.13.3 Sales, Price, Cost, Gross Profit, and Revenue 66
• 6.14 Biocon 67
  • 6.14.1 Company Profile 67
  • 6.14.2 Product Information 68
  • 6.14.3 Sales, Price, Cost, Gross Profit, and Revenue 68

7 Diabetes Drugs Manufacturing Cost Analysis 69

• 7.1 Diabetes Drugs Key Raw Materials Analysis 69
  • 7.1.1 Key Raw Materials 69
  • 7.1.2 Key Raw Materials Price Trend 70
  • 7.1.3 Key Suppliers of Raw Materials 70
• 7.2 Proportion of Manufacturing Cost Structure 71
• 7.3 Manufacturing Process Analysis of Diabetes Drugs 72
• 7.4 Diabetes Drugs Industrial Chain Analysis 73

8 Marketing Channel, Distributors and Customers 74

• 8.1 Marketing Channel 74
• 8.2 Diabetes Drugs Distributors List 76

9 Market Dynamics 78

• 9.1 Market Trends 78
• 9.2 Opportunities 78
• 9.3 Market Drivers 78
• 9.4 Challenges 79
• 9.5 Influence Factors 79

10 Global Diabetes Drugs Market Forecast 80

• 10.1 Global Diabetes Drugs Sales, Revenue Forecast 80
  • 10.1.1 Global Diabetes Drugs Sales Growth Rate Forecast (2019-2025) 80
  • 10.1.2 Global Diabetes Drugs Revenue and Growth Rate Forecast (2019-2025) 81
  • 10.1.3 Global Diabetes Drugs Price and Trend Forecast (2019-2025) 82
• 10.2 Global Diabetes Drugs Sales Forecast by Regions (2019-2025) 82
  • 10.2.1 North America Diabetes Drugs Sales, Revenue Forecast (2019-2025) 84
  • 10.2.2 Europe Diabetes Drugs Sales, Revenue Forecast (2019-2025) 86
  • 10.2.3 China Diabetes Drugs Sales, Revenue Forecast (2019-2025) 88
  • 10.2.4 India Diabetes Drugs Sales, Revenue Forecast (2019-2025) 90
• 10.3 Global Diabetes Drugs Sales, Revenue and Price Forecast by Type (2019-2025) 91

11 Research Findings and Conclusion 94

12 Methodology and Data Source 95

• 12.1 Methodology/Research Approach 95
  • 12.1.1 Research Programs/Design 95
  • 12.1.2 Market Size Estimation 96
  • 12.1.3 Market Breakdown and Data Triangulation 97
• 12.2 Data Source 98
  • 12.2.1 Secondary Sources 98
  • 12.2.2 Primary Sources 99
• 12.3 Author List 100
• 12.4 Disclaimer 101